AxoGen Debt to Equity Ratio 2010-2024 | AXGN
Current and historical debt to equity ratio values for AxoGen (AXGN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. AxoGen debt/equity for the three months ending December 31, 2024 was 0.64.
| AxoGen Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-12-31 | $0.10B | $0.10B | 0.96 |
| 2024-09-30 | $0.09B | $0.10B | 0.93 |
| 2024-06-30 | $0.09B | $0.10B | 0.97 |
| 2024-03-31 | $0.09B | $0.09B | 1.00 |
| 2023-12-31 | $0.10B | $0.10B | 1.06 |
| 2023-09-30 | $0.10B | $0.10B | 0.99 |
| 2023-06-30 | $0.09B | $0.10B | 0.97 |
| 2023-03-31 | $0.09B | $0.10B | 0.94 |
| 2022-12-31 | $0.09B | $0.10B | 0.94 |
| 2022-09-30 | $0.09B | $0.10B | 0.93 |
| 2022-06-30 | $0.09B | $0.10B | 0.93 |
| 2022-03-31 | $0.09B | $0.10B | 0.91 |
| 2021-12-31 | $0.10B | $0.11B | 0.85 |
| 2021-09-30 | $0.10B | $0.12B | 0.82 |
| 2021-06-30 | $0.09B | $0.12B | 0.77 |
| 2021-03-31 | $0.08B | $0.12B | 0.65 |
| 2020-12-31 | $0.08B | $0.12B | 0.64 |
| 2020-09-30 | $0.07B | $0.12B | 0.59 |
| 2020-06-30 | $0.05B | $0.12B | 0.42 |
| 2020-03-31 | $0.02B | $0.12B | 0.17 |
| 2019-12-31 | $0.02B | $0.13B | 0.17 |
| 2019-09-30 | $0.02B | $0.14B | 0.14 |
| 2019-06-30 | $0.02B | $0.14B | 0.14 |
| 2019-03-31 | $0.02B | $0.14B | 0.14 |
| 2018-12-31 | $0.01B | $0.15B | 0.09 |
| 2018-09-30 | $0.01B | $0.15B | 0.08 |
| 2018-06-30 | $0.01B | $0.15B | 0.07 |
| 2018-03-31 | $0.03B | $0.02B | 1.54 |
| 2017-12-31 | $0.03B | $0.03B | 1.34 |
| 2017-09-30 | $0.03B | $0.01B | 3.00 |
| 2017-06-30 | $0.03B | $0.01B | 2.78 |
| 2017-03-31 | $0.03B | $0.01B | 2.57 |
| 2016-12-31 | $0.03B | $0.02B | 2.11 |
| 2016-09-30 | $0.03B | $0.00B | 26.88 |
| 2016-06-30 | $0.03B | $0.00B | 10.37 |
| 2016-03-31 | $0.03B | $0.01B | 5.92 |
| 2015-12-31 | $0.03B | $0.01B | 3.48 |
| 2015-09-30 | $0.03B | $0.01B | 2.66 |
| 2015-06-30 | $0.03B | $0.00B | -8.20 |
| 2015-03-31 | $0.03B | $0.00B | -42.35 |
| 2014-12-31 | $0.03B | $-0.01B | -2.46 |
| 2014-09-30 | $0.03B | $-0.01B | -2.97 |
| 2014-06-30 | $0.03B | $-0.01B | -4.12 |
| 2014-03-31 | $0.03B | $0.00B | -7.65 |
| 2013-12-31 | $0.03B | $0.00B | 201.67 |
| 2013-09-30 | $0.03B | $0.00B | 6.23 |
| 2013-06-30 | $0.03B | $-0.01B | -2.69 |
| 2013-03-31 | $0.02B | $-0.01B | -3.97 |
| 2012-12-31 | $0.02B | $0.00B | -8.15 |
| 2012-09-30 | $0.01B | $0.00B | 7.05 |
| 2012-06-30 | $0.01B | $0.00B | 2.01 |
| 2012-03-31 | $0.01B | $0.00B | 1.54 |
| 2011-12-31 | $0.01B | $0.01B | 1.06 |
| 2011-09-30 | $0.01B | $0.01B | 0.82 |
| 2011-06-30 | $0.00B | $0.01B | 0.05 |
| 2011-03-31 | $0.00B | $0.01B | 0.02 |
| 2010-12-31 | $0.02B | $-0.01B | -1.55 |
| 2010-09-30 | $0.00B | $0.01B | 0.01 |
| 2010-06-30 | $0.00B | $0.01B | 0.01 |
| 2010-03-31 | $0.00B | $0.01B | 0.04 |
| 2009-12-31 | $0.01B | $0.01B | 0.52 |
| 2009-09-30 | $0.00B | $0.00B | 1.44 |
| 2009-06-30 | $0.00B | $0.00B | 1.31 |
| 2009-03-31 | $0.00B | $0.00B | 1.44 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.721B | $0.187B |
| AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $184.872B | 80.97 |
| Thermo Fisher Scientific (TMO) | United States | $161.944B | 19.59 |
| Alcon (ALC) | Switzerland | $48.146B | 32.00 |
| Edwards Lifesciences (EW) | United States | $44.378B | 29.03 |
| IDEXX Laboratories (IDXX) | United States | $35.062B | 40.55 |
| DexCom (DXCM) | United States | $27.989B | 43.26 |
| IQVIA Holdings (IQV) | United States | $27.341B | 15.13 |
| Mettler-Toledo (MTD) | United States | $22.312B | 26.01 |
| STERIS (STE) | Ireland | $22.081B | 25.25 |
| Waters (WAT) | United States | $20.688B | 29.30 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.273B | 0.00 |
| Hologic (HOLX) | United States | $13.059B | 14.09 |
| Sysmex ADR (SSMXY) | Japan | $11.620B | 0.00 |
| Penumbra (PEN) | United States | $11.341B | 89.01 |
| Globus Medical (GMED) | United States | $9.871B | 22.86 |
| Masimo (MASI) | United States | $8.698B | 36.50 |
| Teleflex (TFX) | United States | $6.355B | 9.78 |
| Glaukos (GKOS) | United States | $5.380B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.407B | 23.09 |
| TransMedics (TMDX) | United States | $3.112B | 91.10 |
| PROCEPT BioRobotics (PRCT) | United States | $2.986B | 0.00 |
| Veracyte (VCYT) | United States | $2.389B | 42.96 |
| LivaNova (LIVN) | United Kingdom | $2.011B | 12.21 |
| Nihon Kohden (NHNKY) | Japan | $1.969B | 10.77 |
| Elekta AB (EKTAY) | Sweden | $1.945B | 17.48 |
| Alphatec Holdings (ATEC) | United States | $1.604B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.266B | 6.40 |
| Pulse Biosciences (PLSE) | United States | $1.145B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.122B | 0.00 |
| Artivion (AORT) | United States | $1.011B | 94.76 |
| OPKO Health (OPK) | United States | $0.927B | 0.00 |
| IRadimed (IRMD) | United States | $0.666B | 34.94 |
| Mesa Laboratories (MLAB) | United States | $0.626B | 13.69 |
| RxSight (RXST) | United States | $0.598B | 0.00 |
| SiBone (SIBN) | United States | $0.581B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.577B | 9.30 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.543B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.506B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.479B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.445B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.403B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.403B | 0.00 |
| NeuroPace (NPCE) | United States | $0.383B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.377B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.334B | 17.87 |
| Pacific Biosciences Of California (PACB) | United States | $0.333B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.310B | 6.58 |
| Neuronetics (STIM) | United States | $0.288B | 0.00 |
| 908 Devices (MASS) | United States | $0.194B | 0.00 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| CVRx (CVRX) | United States | $0.191B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.180B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.179B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.165B | 0.00 |
| Accuray (ARAY) | United States | $0.159B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.158B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.132B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.116B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.108B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.100B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.086B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.079B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 10.75 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.055B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.038B | 0.00 | |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.20 |